GSK Acquires Argentine Generics Firm for $253 Million
08:50 AM | June 11, 2010 | Deepti Ramesh
GlaxoSmithKline (GSK; London) says it has acquired Laboratorios Phoenix (Buenos Aires), a leading Argentine pharmaceutical business, for a cash consideration of about $253 million, to accelerate sales...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.